Priya Singh Selected Research

Priya Singh Research Topics

Disease

9	Neoplasms (Cancer) 03/2022 - 03/2019
6	Breast Neoplasms (Breast Cancer) 03/2021 - 02/2018
5	COVID-19 06/2021 - 01/2020
4	Carcinoma (Carcinomatosis) 06/2022 - 02/2018
3	Metabolic Bone Diseases (Osteopenia) 02/2022 - 08/2019
3	Infections 01/2021 - 07/2014
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 02/2018 - 04/2017
2	Triple Negative Breast Neoplasms 12/2022 - 03/2022
2	Inflammation (Inflammations) 07/2021 - 01/2021
2	Tuberculosis (Tuberculoses) 09/2020 - 07/2014
2	Acquired Immunodeficiency Syndrome (AIDS) 08/2020 - 07/2014
2	Leprosy (Hansen's Disease) 08/2019 - 07/2014
1	Liver Neoplasms (Liver Cancer) 06/2022
1	Neuroinflammatory Diseases 05/2022
1	Wounds and Injuries (Trauma) 04/2022
1	Chronic Renal Insufficiency 02/2022
1	Osteoporosis 02/2022
1	Venous Insufficiency 02/2022
1	Renal Insufficiency (Renal Failure) 02/2022
1	Hemolysis 01/2022
1	Rheumatoid Arthritis 05/2021
1	Reinfection 01/2021
1	Glioblastoma (Glioblastoma Multiforme) 01/2021
1	Glioma (Gliomas) 01/2021
1	Hepatocellular Carcinoma (Hepatoma) 01/2021
1	Obesity 01/2021
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2021
1	Rickets (Rachitis) 12/2020
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 10/2020
1	Pathologic Complete Response 10/2020
1	Body Weight (Weight, Body) 09/2020
1	Dementia (Dementias) 08/2020

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 05/2022 - 03/2019
4	Pharmaceutical PreparationsIBA 06/2022 - 05/2017
3	DNA (Deoxyribonucleic Acid)IBA 03/2021 - 01/2020
2	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2022 - 02/2018
2	Imatinib Mesylate (Gleevec)FDA Link 06/2022 - 01/2021
2	salicylhydroxamic acid (SHAM)IBA 02/2022 - 09/2020
2	thymoquinoneIBA 07/2021 - 05/2021
2	Biological ProductsIBA 03/2021 - 01/2020
2	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2021 - 01/2021
2	VaccinesIBA 01/2021 - 01/2021
2	rifamycin BIBA 09/2020 - 07/2014
2	Coloring Agents (Dyes)IBA 01/2020 - 02/2018
2	Nucleic AcidsIBA 01/2020 - 07/2019
2	ErbB Receptors (EGF Receptor)IBA 01/2019 - 12/2014
1	Cysteine (L-Cysteine)FDA Link 12/2022
1	Whey ProteinsIBA 12/2022
1	Hyaluronic Acid (Hyaluronan)IBA 06/2022
1	ethyleneIBA 04/2022
1	Neomycin FDA LinkGeneric 04/2022
1	neamineIBA 04/2022
1	piperlongumineIBA 03/2022
1	Diosmin (Daflon)IBA 02/2022
1	diosmetinIBA 02/2022
1	Diphosphonates (Bisphosphonates)IBA 02/2022
1	FlavonoidsIBA 02/2022
1	Levofloxacin (Levaquin)FDA Link 01/2022
1	carbopol 940 (sodium polyacrylate)IBA 07/2021
1	guar gum (guaran)IBA 07/2021
1	AcrylonitrileIBA 07/2021
1	Environmental Pollutants (Pollutants, Environmental)IBA 06/2021
1	Air Pollutants (Pollutants, Air)IBA 06/2021
1	Schiff Bases (Schiff Base)IBA 03/2021
1	benzimidazoleIBA 03/2021
1	Estrogens (Estrogen)FDA Link 03/2021
1	CopperIBA 03/2021
1	Arginine (L-Arginine)FDA Link 01/2021
1	Estrogen ReceptorsIBA 01/2021
1	EnzymesIBA 01/2021
1	periodate-oxidized adenosineIBA 01/2021
1	MethyltransferasesIBA 01/2021
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2021
1	polyolIBA 01/2021
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021
1	Temozolomide (Temodar)FDA LinkGeneric 01/2021
1	Adenosine Diphosphate (ADP)IBA 01/2021
1	Disinfectants (Biocides)IBA 01/2021
1	DisulfidesIBA 01/2021
1	ColforsinIBA 01/2021
1	Intercalating AgentsIBA 01/2021
1	LactoferrinIBA 01/2021
1	LigandsIBA 01/2021
1	NAD (NADH)IBA 01/2021
1	ProdrugsIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	Cadherins (E-Cadherin)IBA 01/2021
1	A-Form DNA (A-DNA)IBA 01/2021
1	Dietary CalciumIBA 12/2020
1	CalciumIBA 12/2020
1	pseudosemiglabrinIBA 08/2020
1	tephrosinIBA 08/2020
1	QuercetinIBA 08/2020

Therapy/Procedure

10	Therapeutics 12/2022 - 12/2014
3	Drug Therapy (Chemotherapy) 01/2021 - 12/2014
1	Nephrectomy 02/2022
1	Personal Protective Equipment 01/2021
1	Immunomodulation 01/2021
1	Radiotherapy 10/2020